The Effect of Eye Mask Applied on Patients Undergoing Coronary Artery Bypass Graft Surgery

Summary

Introduction: Coronary Artery Bypass Graft (CABG) performed with open heart surgery technique is a successful operation in the treatment of cardiovascular diseases. Incision of the sternum region, saphenous vein graft, sternal retraction, presence of chest and mediastinal tubes cause pain. The pain experienced by the patients, the complications related to the disease they have, and the stress they experience cause an increase in sleep problems. In addition, the increase in sympathetic activity after surgery and nursing care interventions also affect sleep quality. The literature reports that sleep disorders affect the working physiology of the heart in patients with cardiac disease, adversely affect heart health and affect postoperative recovery. In addition, since sleep disorders are also associated with cardiovascular diseases, it is of great importance to improve the sleep quality of this group of patients. One of the non-pharmacological nursing interventions is the eye patch. The eye patch is an instrument made of fabric, with an elastic strap, aimed at pure darkness by diverting all light from the patient's eyes. The main physiological purpose of using an eye patch is to adjust the hormones melatonin and cortisol, which affect the circadian rhythm. As a result, it is thought that the eye patch will prevent patients from being exposed to excessive light in the hospital environment, the regulation of hormones and sleep quality will improve, and the pain will decrease.

Purpose: The aim of this study is to examine the effect of eye patch applied to patients undergoing coronary artery bypass graft surgery on sleep quality and pain.

Method: Individuals who have undergone coronary artery bypass graft surgery in accordance with the sampling inclusion criteria will be randomly assigned to the experimental and control groups by block randomization. After determining the groups, each patient in the experimental and control groups, whose written consent was obtained, will have the first researcher fill out the Descriptive Characteristics Form, Richards-Campbell Sleep Questionnaire and Numerical Pain Scale on the morning of the first night they spent in the clinic.

Patients in the experimental group will be given the "standard care" and "eye patch" application in the clinic on their 2nd and 3rd nights in the clinic. The patients in the control group will only be provided with the "standard care" in the clinic on their 2nd and 3rd nights in the clinic. Patients in both groups will be asked to fill out the Richards-Campbell Sleep Questionnaire and Numerical Pain Scale forms in the mornings of the 2nd and 3rd nights.

Conditions

• Coronary Artery Disease
• Sleep Disorder
• Pain, Postoperative

Interventions

BEHAVIORAL

eye mask

* First day morning The Introductory Characteristics Form will be filled. * First day night Standard care will be given * Second day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled * Second day night Standard care will be given + eye patch will be applied (22:00-06:00) * Third day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled * Third day night Standard care will be given + eye patch will be applied (22:00-06:00) * Fourth day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled

BEHAVIORAL

standart care

Control group (n) * First day morning The Introductory Characteristics Form will be filled. * First day night Standard care will be given * Second day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled * Second day night Standard care will be given * Third day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled * Third day night Standard care will be given) * Fourth day morning Richards-Campbell Sleep Questionnaire and Numerical Pain Scale to be filled

Sponsors & Collaborators

• Kutahya Health Sciences University

  lead OTHER

Principal Investigators

• Burcu NAL, Msc RN · kütahya health sciences university

• Gülşah GÜROL ARSLAN, Msc RN · Dokuz Eylul University

• Mehmet Ali ASTARCIOĞLU, Doctor · kütahya health sciences university

• Ali İhsan PARLAR, Doctor · kütahya health sciences university

• Necibe DAĞCAN, Msc RN · Dokuz Eylul University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-07-10

Primary Completion

2024-01-01

Completion

2024-03-01

Countries

• Turkey (Türkiye)

Study Locations